Atomo Diagnostics (ASX:AT1): Commercialisation is going into higher gear
On 27 August 2025 we spoke to John Kelly, CEO of Atomo Diagnostics (ASX:AT1), about progress the company is making towards profitability and how aspects of the Atomo pipeline, such as the syphylis diagnostic, are making this company world-class.
